TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37−0.03 (-2.14%)
Close on Nov 18, 2026Market cap $87.31MP/E –Yield –
TuHURA Biosciences total assets
Total assets on the balance sheet at the end of each period.
TuHURA Biosciences's total assets was $31.75M at Jun 30, 2026. For fiscal 2025 it was $27.35M, up 587.4% from the year before. Over ten years it grew 65.0% a year on average. The highest annual figure on record is $27.35M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.35M | +587.4% |
| FY2023 | Jun 30, 2023 | $3.98M | -75.1% |
| FY2022 | Jun 30, 2022 | $15.95M | +17.8% |
| FY2021 | Jun 30, 2021 | $13.54M | +361.0% |
| FY2020 | Jun 30, 2020 | $2.94M | -27.2% |
| FY2019 | Jun 30, 2019 | $4.04M | -42.9% |
| FY2018 | Jun 30, 2018 | $7.07M | -10.6% |
| FY2017 | Jun 30, 2017 | $7.91M | +24.5% |
| FY2016 | Jun 30, 2016 | $6.36M | +47.2% |
| FY2013 | Dec 31, 2013 | $4.32M | +2262.2% |
| FY2012 | Dec 31, 2012 | $182.83K | +22611.8% |
| FY2011 | Dec 31, 2011 | $805 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $31.75M | -8.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $29.70M | +102.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $27.35M | +587.4% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $25.70M | +281.3% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $34.62M | +249.1% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $14.64M | +10.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $3.98M | -75.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $6.74M | -47.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $9.92M | -44.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $13.21M | -40.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $15.95M | +17.8% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $12.80M | -32.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $17.72M | -13.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $22.34M | -3.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $13.54M | +361.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $18.85M | +269.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $20.49M | +214.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $23.13M | +176.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.94M | -27.2% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $5.10M | +107.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $6.51M | +61.2% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $8.36M | +76.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $4.04M | -42.9% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.46M | -74.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $4.04M | -66.9% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $4.75M | -67.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $7.07M | -10.6% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $9.68M | +313.4% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $12.22M | +239.9% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $14.45M | +186.3% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $7.91M | +24.5% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $2.34M | +102.6% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $3.59M | +64.5% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $5.05M | +16.9% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $6.36M | +17.9% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $1.16M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $2.18M | – |
| Q4 FY2013CQ4 2013 | Dec 31, 2013 | $4.32M | – |
| Q3 FY2013CQ3 2013 | Sep 30, 2013 | $5.39M | – |
See a number that looks wrong?